Microchip Technology Provides Business Update for Fourth Quarter Fiscal 2020
CHANDLER, Ariz., March 02, 2020 (GLOBE NEWSWIRE) — (NASDAQ: MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected […]
Virtu Completes Previously Announced Term Loan Repricing
NEW YORK, March 02, 2020 (GLOBE NEWSWIRE) — Virtu Financial, Inc. (NASDAQ: VIRT) (“Virtu” or the “Company”), a leading provider […]
BeiGene Reports Fourth Quarter and Full Year 2019 Financial Results
CAMBRIDGE, Mass. and BEIJING, China, March 02, 2020 (GLOBE NEWSWIRE) — BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical […]
Itamar™ Medical and Clalit Research Institute Establish Research Collaboration to Explore WatchPAT Signals’ Ability to Predict Health Outcomes Using Existing Big Data and Artificial Intelligence
Study will evaluate how raw signals from tens of thousands of WatchPAT recordings conducted over the last 10 years in […]
GenMark Diagnostics Reports Fourth Quarter and Full Year 2019 Results
CARLSBAD, Calif., March 02, 2020 (GLOBE NEWSWIRE) — GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular […]
PowerFleet Sets Fourth Quarter and Full Year 2019 Conference Call for Thursday, March 12, 2020 at 8:30 a.m. ET
WOODCLIFF LAKE, N.J., March 02, 2020 (GLOBE NEWSWIRE) — PowerFleet, Inc. (Nasdaq: PWFL), a global leader and provider of subscription-based […]
TransMedics Reports Fourth Quarter and Full Year 2019 Financial Results
ANDOVER, Mass., March 02, 2020 (GLOBE NEWSWIRE) — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is […]
ascena retail group, inc. Announces Fiscal 2020 Second Quarter Financial Results Conference Call on Monday, March 9, 2020
MAHWAH, N.J., March 02, 2020 (GLOBE NEWSWIRE) — ascena retail group, inc. (Nasdaq – ASNA) (the “Company” or “ascena”) today […]
Ziopharm Oncology Reports Financial Results for Fourth Quarter and Full Year 2019
– Emergence of TCR program, Controlled IL-12 data, strengthened team highlight 2019 –– Balance sheet strengthened; cash of approximately $177 […]
uniQure and Gen-X Enter into Research Collaboration and License Agreement for the Development of Novel Synthetic Promoters
~ Gen-X Will Work with uniQure During an Exclusivity Period to Identify Novel Promoters for uniQure’s Product Portfolio ~~ uniQure […]
